Sort   by:  
 Page size 
UnknownImpact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon.
Not available
S-EPMC5929186 | biostudies-literature
UnknownDirect venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
Not available
S-EPMC4371633 | biostudies-literature
UnknownControlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates.
Not available
S-EPMC4527105 | biostudies-literature
UnknownSterile protection against human malaria by chemoattenuated PfSPZ vaccine.
Not available
S-EPMC10906480 | biostudies-literature
UnknownSafety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Not available
S-EPMC8981424 | biostudies-literature
UnknownSafety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults.
Not available
S-EPMC6090339 | biostudies-literature
UnknownSafety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.
Not available
S-EPMC6553883 | biostudies-literature
UnknownMalaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.
Not available
S-EPMC12823417 | biostudies-literature
UnknownAdvancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.
Not available
S-EPMC5928718 | biostudies-literature
UnknownControlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response.
Not available
S-EPMC8785382 | biostudies-literature
Sort   by:  
 Page size